Magnus Aassved Hjort
Background and activities
Medical doctor from University of Tromsø (2010) and resident at Children's Clinic, St. Olavs hospital from 2012.
I did my PhD in the Rø/Børset-lab, Myeloma group, Dept of Clinical and Molecular Medicine, NTNU from 2014-2018, exploring the importance of the phosphatase PRL-3 in the B cell malignancies B-ALL, Hodgkin lymphoma and multiple myeloma. Here we found that PRL-3 was expressed at a higher level in cancer cells compared to normal cells. Further we found that PRL-3 was important for cancer cell migration and proliferation. This indicates that PRL-3 could be a possible novel treatment target in B cell malignancies.
From November 2018 I'm a 50 % researcher with a projected related to treatment-related mortality in the NOPHO ALL 2008-protocol.